Daily Stock List
Gazprom OAO (OGZPY)
InvestorPlace reported today on Gazprom OAO (OGZPY), Energy & Capital and Real Pennies did earlier, and we are highlighting the Company as "One to Watch" here at the QualityStocks Daily Newsletter.
Owner and operator of Russia's Unified Gas Supply System, Gazprom extracts, transports, stores and sells natural gas. The Company's major business lines are geological exploration, production, transportation, storage, processing and sales of gas, gas condensate and oil, and the generation and marketing of heat and electric power. Gazprom holds the world's largest natural gas reserves. Their share in worldwide and Russian gas reserves makes up 18 and 70 percent, respectively.
Gazprom has a monopoly in supplying gas in the Russian Federation, and the company exports natural gas to Western Europe. They export gas to over 30 countries within and beyond the former Soviet Union. The aforementioned Unified Gas Supply System consists of 161.7 thousand kilometers of gas trunklines and branches; 215 pipeline compressor stations; 6 gas and gas condensate treatment facilities; and 25 underground gas storage facilities.
In addition, Gazprom operates gas and hydropower generating facilities with an installed capacity of 37 gigawatts. They also operate a network of gas and compressed natural gas (CNG) filling stations. Currently, Gazprom actively implements large-scale projects targeting exploiting gas resources of the Yamal Peninsula, Arctic Shelf, Eastern Siberia and the Far East, as well as hydrocarbons exploration and production projects internationally.
In January 2013, Gazprom announced that the Zapolyarnoye field was brought to its full capacity – 130 billion cubic meters of gas a year. It became the most productive field in Russia. In addition, they also announced in January that the Adler CHPS – the most state of-the-art power generating facility in Sochi, Russia – was commissioned.
This week, Gazprom announced that Mr. Yury Spektor was elected as Director General of Gazprom Promgaz. Mr. Spektor graduated from Ufa Oil Institute, majoring in Construction of Gas and Oil Pipelines, Gas and Oil Storages. He is a Doctor of Engineering, Professor.
Gazprom Promgaz is the Company's leading research center. They focus on regional energy policy substantiation, gasification, gas distribution and utilization, minor fields and CBM resources development. Gazprom Promgaz is also the general designer for the Russian Regions Gasification Program.
Furthermore, this week, the Company reported that Gazprom and Greece addressed the potential privatization of DEPA. They reported that the Gazprom delegation paid a visit to the Greek Republic. A working meeting with Antonis Samaras, the Greek Republic Prime Minister, took place as part of the visit. The parties addressed the cooperation in the gas sector and special consideration was given to Gazprom's potential participation in the privatization of Greek DEPA Group. DEPA focuses on wholesale purchases, sales and supplies of natural gas to industrial consumers and households in Greece.
We have Gazprom OAO (OGZPY) in our sightlines as "One to Watch" here at the QualityStocks Daily Newsletter.
Gazprom OAO (OGZPY), closed Wednesday's trading session at $9.04, up 1.70%, on 619,437 volume with 297 trades. The stock's 52-week low/high is $8.56/$13.63.
Innovative Composites International, Inc. (ICIZF)
Today we are highlighting Innovative Composites International, Inc. (ICIZF), here at the QualityStocks Daily Newsletter.
Innovative Composites International, Inc. is a high-tech engineering and manufacturing company whose shares trade on the OTCQX International. The Company is successfully commercializing a patent protected line of state-of-the-art composite products. Innovative Composites is targeting the multi-billion dollar transportation and housing markets. The Company has their corporate headquarters in Toronto, Ontario.
Innovative Composites International's goal is to utilize their proprietary "green" composite materials and building systems to provide innovative, engineered product solutions to markets that include prefabricated modular housing, shelters and containers, and industrial applications. The Company has new designs including prefabricated modular homes, cargo containers as well as structural insulated panels. Their two diverse product lines are Structure-Lite (their flagship product) and EcoScape.
Structure-Lite composite panels are the foundation for a number of their products. The panels are used for cargo containers, truck body containers and highway sound barrier panels. The panels consist of recycled materials including plastic water bottles. The panels are environmentally friendly and made with inexpensive, readily available raw materials. A vital component of the Company's composite panels is their unique thermoplastic fiber reinforced composite skin material. The skin forms the outer layer of the panels and offers high-quality durability and strength to the lightweight panels. Innovative Composites International owns and manufactures the thermoplastic fiber reinforced composite skin material.
Concerning Prefabricated Modular Housing, the Company has their EcoScape houses. The design of the EcoScape line is for easy, quick assembly, with the ability to be completed in only a few days. The strength and durability of the panels make them suited for disaster prone areas, being both earthquake and hurricane resistant.
At the beginning of March, Innovative Composites International reported their financial results for the fiscal 2013 first quarter ended December 31, 2012. They had revenue of $587,000 for the first quarter of fiscal 2013, in comparison to $907,000 for the first quarter of fiscal 2012. The decline in revenue was mainly because of the departure of one customer who made the decision to manufacture in-house the product that the Company was supplying. The revenue for the quarter was garnered mainly from the sale of specifically engineered enclosures as from sales of Mattex and load floors to the automotive sector.
Gross margin for the quarter, after adjustment for IFRS related items, was approximately $187,000, in comparison to $121,000 for the corresponding period in 2012. Concerning Operational highlights, the Company continued to receive a continual flow of purchase orders for specifically engineered enclosures from a global leader in heating, air-conditioning and refrigeration (HVAC) equipment. Additionally, the Company developed a new "load floor" design for the automotive sector using proprietary RMor Skin certified by an independent laboratory as meeting or exceeding the specifications of Chrysler, Ford and GM.
Innovative Composites International, Inc. (ICIZF), closed Wednesday's trading session at $0.04, up 100.00%, on 50,000 volume with 2 trades. The stock's 52-week low/high is $0.02/$0.764.
Vista International Technologies, Inc. (VVIT)
Nebula Stocks and OTC Picks reported previously on Vista International Technologies, Inc. (VVIT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTC Markets' OTCQB, Vista International Technologies, Inc. is a pioneer in efficient Waste-to-Energy technology. Their technology has low costs of installation and operation. The technology allows for the processing of practically any hydrocarbon-based waste product. These include municipal solid waste, waste tires, waste coal, sewage sludge, animal waste, and biomass, among others. Vista International Technologies has their headquarters in Englewood, Colorado.
The Company's Waste-to-Energy systems are emission friendly and very efficient. They can be used to produce heat, steam, and/or electricity. Vista International Technologies' Waste-to-Energy division develops environmentally safe energy infrastructures that produce electricity, heat, steam, alternative fuels, and natural gas and chemical products utilizing a proprietary patented technology.
The Gasification system converts municipal solid waste (MSW), biomass, tires, medical waste and other solid carbon based materials into electricity and steam energy. The system does this while capturing the pollutants and turning them into useful products. Therefore, this makes the unit essentially emissions free.
The Company also has a focus on Low Wind Speed Generators. Their wind equipment has undergone installation in different countries over the past years. These include Australia, Brunei, Egypt, India, Indonesia, Jordan, Malaysia, Myanmar, New Zealand, Saudi Arabia, South Africa, the South Pacific Islands, the UK and the United States. Concerning Alternative Fuels, Vista produces a high-octane liquid fuel that is used as a gasoline additive or a straight fuel on its own. Additionally, pertaining to Energy Saving and Full Spectrum Lighting, their Light Division has worked with several inventors over the past decade or so in developing different light bulbs.
Today, Vista International Technologies gave an update on revenue generated by their tire division and new developments with their Thermal Gasifier technology. Revenues for the fourth quarter of 2012 were up approximately 55 percent year over year, exceeding $175,000. These increases were primarily because of increased sales of processed tire material at their tire processing facility in Hutchins, Texas. January 2013 revenues were up approximately 75 percent year over year, and 30 percent sequentially.
Pertaining to their Waste-to-Energy business, Vista has seen a major increase in interest for their proprietary Thermal Gasifier technology in recent months, in domestic and international markets.
Vista International Technologies, Inc. (VVIT), closed Wednesday's trading session at $0.10, up 150.00%, on 93,500 volume with 12 trades. The stock's 52-week low/high is $0.031/$0.35.
Minfocus Exploration Corp. (MFX.V)
Today we are highlighting Minfocus Exploration Corp. (MFX.V), here at the QualityStocks Daily Newsletter.
Minfocus Exploration Corp. is concentrating on the continued growth of a portfolio of Platinum Group Element (PGE) rich resource assets through exploration, acquisitions and joint ventures in Northwest Ontario, Canada. The Company's management group has a record of multiple discoveries of deposits globally. They have over 15 years experience and success exploring for PGE-rich resources in Ontario. This includes the discovery of the first Platinum-rich PGE deposit, the Panoramic Current Lake deposit (700,000-plus oz Pt-Eq).
Incorporated in 1994, Minfocus Exploration lists on the TSX Venture Exchange. The Company is based in Toronto, Ontario. Minfocus Exploration's management group also has extensive strength and success in corporate development, mergers and acquisitions (M&A) and project development.
The Company's main property, Nipigon Reefs, is less than 15 km from
Panoramic Resources' Current Lake deposit and 35 km from NA Palladium's producing Pt/Pd mine. The 2012 Minfocus Exploration drilling at their Nipigon Reefs Project confirmed the existence of multiple significant PGE mineralized layers with drill core interval lengths up to 5.0 meters thick and greater than 0.5g/t 3E.
Yesterday, Minfocus Exploration announced that they received additional assay results from their recently completed program of diamond drilling on the Chief Peter Property. The results confirmed near surface sample intervals of 4.0 to 5.0 meters with greater than 2.0 g/tonne combined Platinum and Palladium and greater than 0.50 percent copper. The Chief Peter Property, under option by Minfocus to earn a 100 percent interest, is in Northwest Ontario very close to the Provincial Highway No. 11, power lines, and the parallel CN rail line between Thunder Bay and Atikokan.
Minfocus Exploration may earn 100 percent interest in the property upon making payments over a 4-year option period to the Optionors totaling $140,000 cash and issuing 300,000 Minfocus Exploration shares, and completing $200,800 in exploration expenditures on the property. This consists of minimum work expenditures in each respective year of $20,800, $45,000, $45,000 and $90,000. Upon earning their 100 percent interest in the Chief Peter Property, the Optionors will be granted a 3 percent Net Smelter Return (NSR). This may be reduced to a 1 percent NSR by Minfocus Exploration making a payment of $500,000 for each 0.5 percent NSR purchased back by Minfocus.
Minfocus Exploration Corp. (MFX.V), closed Wednesday's trading session at $0.03, even for the day. The stock's 52-week low/high is $0.02/$0.06.
Nordex Explosives Ltd. (NXX.V)
We are reporting on Nordex Explosives Ltd. (NXX.V), here at the QualityStocks Daily Newsletter.
Nordex Explosives Ltd. is a manufacturer and distributor of explosives for the mining, quarry and road construction industries. The Company is the exclusive supplier of the Econotrim and Ezicharge Johnex Explosives products in Canada. Nordex is located in a strategic geographic location to service the "heart" of the mining industry in Canada. The Company's main production facility is outside of Kirkland Lake, Ontario. Nordex Explosives has their corporate headquarters in Mississauga, Ontario.
The Company produces premium explosive products for their clients, and other explosive distributors and manufacturers. They manufacture a complete line of emulsions, ANFO and specialty products. They additionally provide a complete line of initiation systems. These include electric, non-electric and electronic detonators, boosters, lead wire and detonating cord.
An example of the Company's products is their NorMAX emulsion product. The NorMAX Detonator Sensitive Emulsion is a high-strength microsphere sensitized packaged emulsion. NorMAX is suitable for surface and underground applications. It is recommended for wet and dry boreholes where small diameter explosives are needed.
Nordex Explosives also holds a variety of mining claims covering 529 hectares in the Township of Melba located 22 kilometers north of Kirkland Lake, Ontario.
This week, Nordex Explosives announced that a Memorandum Of Understanding (MOU) agreement has been reached with Wahgoshig Limited Partnership via their general partner Wahgoshig Resources, Inc. The parties have agreed to enter into a working relationship that's expected to be structured as a limited partnership. Nordex and Wahgoshig intend to pursue business opportunities with those customers operating in the mining, quarry and construction industries - in which Wahgoshig have a working agreement and which have a need for the use of explosive products, accessories and related services.
Wahgoshig has agreed to work with Nordex Explosives in an exclusive manner. This is to pursue the explosive business of those customers that require the supply of explosive products, accessories and related services in the geographic territory where the Wahgoshig First Nation holds "territorial rights". Nordex Explosives earlier announced their intention to enter into a working relationship with the Wabun Tribal Council through the formation of a limited partnership expected to be called "Niimki Explosives".
Nordex Explosives Ltd. (NXX.V), closed Wednesday's trading session at $0.54, down 3.57%, on 48,500 volume. The stock's 52-week low/high is $0.31/$0.70.
OSL Holdings, Inc. (OSLH)
FeedBlitz and SmallCapVoice reported recently on OSL Holdings, Inc. (OSLH), and today we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.
OSL Holdings, Inc. is a developer of technology platforms that enable real-time sales and trend information exchange between brands and retailers. The Company develops or acquires business units to collect and transmit real-time consumer and business sales data to facilitate the sale of data, manage electronic marketplaces, operate real-time loyalty rewards and transact with buyers in multiple channels. OSL Holdings' shares trade on the OTC Markets' OTCQB. The Company has their corporate headquarters in Orangeburg, New York.
OSL Holdings intention is to sell data to manufacturers for designated markets. These include urban retail, convenience and/or liquor stores. The Company plans to facilitate developing electronic marketplaces with real-time buy-side and sell-side capabilities for numerous private and public markets. Their intention is to operate a real-time loyalty rewards platform that can facilitate the earning and redemption of their rewards currency at the point of the transaction and on future transactions.
The Company's THINKplatform™ is a transaction-centric social network. The THINKplatform™ interactively identifies, incentivizes and connects communities of retailers, suppliers, and consumers. It accomplishes this while generating deep data and valuable analytics. The THINKplatform™ consists of three business units, which are thinkREWARDS™, thinkDIVERSITY™ and thinkDATAnow™
OSL Holdings' thinkREWARDS™ is a universal, real-time, portable loyalty program that can be used for everyday purchases practically anywhere. The thinkDIVERSITY™ Marketplace will enable corporations to confidently connect with different suppliers; it enables corporations to achieve targeted diversity spending. The thinkDATAnow™ unit is creating a network of data capture points while providing ready to use structured data to connect, inform and transact retail value chain. It enables real-time information sharing between large manufacturers and independent retailers.
OSL plans to take advantage of their business units to connect buyers, sellers and channels. Their goal is for each venture to scale revenues and their respective offerings to their specific market(s) or across markets.
OSL Holdings, Inc. (OSLH), closed Wednesday's trading session at $0.15, up 36.36%, on 25,800 volume with 6 trades. The stock's 52-week low/high is $0.0101/$110.00.
BioSolar, Inc. (BSRC)
TheLightningPicks, Stock Roach, StockHideout, and the BioSolar Newsletter reported earlier on BioSolar, Inc. (BSRC), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
BioSolar, Inc. is a developer of innovative products and materials that reduce the cost of photovoltaic (PV) solar modules. They are the first company to introduce a new dimension of cost reduction through replacing petroleum-based plastic solar cell components with durable bio-based materials. BioBacksheet is BioSolar's first backsheet product. BioSolar lists on the OTCQB; the Company has their headquarters in Santa Clarita, California.
BioSolar materials can be used as drop-in replacements directly in conventional manufacturing processes. BioBacksheet is presently available to solar manufacturers. BioSolar is currently developing EcoBacksheet, their second backsheet product that will further reduce the cost of solar energy.
The design of the Company's first commercially available line of BioSolar Backsheets is specifically for c-Si PV module manufacturers. These backsheets will be available in rolls of film for direct use in lamination and roll-to-roll assembly systems. In addition, BioSolar is undertaking R&D efforts on a modified version of their bio-based materials for use in thin film substrates.
BioSolar is also working on a BioSolar Superstrate. In addition, the Company anticipates developing a line of bio-based resins for injection molding applications in creating diverse housing and packaging components for solar panels and arrays.
In December 2012, BioSolar announced critical cost saving measures that the Company believes would allow them to benefit from a more competitive marketplace for solar subcomponents. To reduce the costs of BioBacksheet further, the Company previously announced that they entered into a contract manufacturing agreement with Stevens Urethane. Stevens Urethane is a foremost contract manufacturer with a proven record of accomplishment in quality and cost competitiveness. Additionally, BioSolar successfully negotiated reduced material and logistics costs by forming mutually beneficial long-term business relationships with their suppliers. BioSolar now has strong backing from vital contractors and suppliers.
Today, BioSolar announced that they received their first commercial BioBacksheet order. The use of the first shipment of BioBacksheet will be for the manufacture of specialty PV panels for electric utility vehicles. Anticipated further shipments will be used by military and other mobile applications. The customer's PV panels feature lightweight, high-power-to-weight ratio, highly durable, customizable shapes, sizes, as well as colors.
BioSolar, Inc. (BSRC), closed Wednesday's trading session at $0.50, up 38.89%, on 105,913 volume with 50 trades. The average volume for the last 60 days is 7,872 and the stock's 52-week low/high is $0.305/$1.25.
RBC Life Sciences, Inc. (RBCL)
Today we are reporting on RBC Life Sciences, Inc. (RBCL), here at the QualityStocks Daily Newsletter.
Headquartered in Irving, Texas, RBC Life Sciences, Inc. mainly engages in the distribution of nutritional supplements and personal care products via network marketing. The Company is an international provider of proprietary nutritional supplements, wound care and pain management products. They offer consumers more than 75 evidence-based wellness, fitness and skin care products. RBC Life Sciences lists on the OTC Markets' OTCQB.
The Company additionally engages in the distribution of medical products to hospitals, nursing homes and home health care agencies. RBC Life Sciences markets and distributes medical products under the MPM Medical, Inc., brand. MPM Medical offers wound care and pain management products. The Company distributes these products primarily in the U.S. to hospitals, nursing homes, clinics and pharmacies via traditional medical/surgical supply dealers, pharmaceutical distributors and RBC's sales representatives.
Through their Nutritional Products segment, RBC Life Sciences distributes wellness products, fitness products and skin care products. Products include herbal formulas, vitamins, minerals, antioxidants and personal care products. Principally in the U.S., Canada and Southeast Asia, the Company distributes Nutritional Products directly through a network consisting of independent Associates and individuals who participate in their NFR program. In certain other markets, they distribute Nutritional Products by way of exclusive license arrangements with third parties.
At the end of January 2013, RBC Life Sciences announced that they were granted US Patent 8357422. This patent protects the Company's unique dietary supplement formulation that nutritionally supports cognitive function, learning and remembering. RBC markets this supplement under the name "Neurobright." The granting of this patent is evidence of the Company's continued commitment to bring effective science-based dietary supplements to the market.
Clinton Howard, Chief Executive Officer, said, "The basis for the patent was an 18-month controlled animal study conducted by Dr. Tres Thompson of the School of Behavioral and Brain Sciences at the University of Texas at Dallas. The study showed that Neurobright increased both cognitive function and psychomotor abilities in animals."
In addition to improved cognitive function, the animals that received Neurobright lived longer than the control animals that were not given Neurobright.
RBC Life Sciences, Inc. (RBCL), closed Wednesday's trading session at $0.19, up 35.71%, on 1,000 volume with 1 trade. The stock's 52-week low/high is $0.0104/$0.29.
Rainbow Coral Corp. (RBCC)
The QualityStocks Daily Newsletter would like to spotlight Rainbow Coral Corp. (RBCC). Today, Rainbow Coral Corp. closed trading at $0.25, up 38.89%, on 263,010 volume with 71 trades. The stock’s average daily volume over the past 60 days is 124,123, and its 52-week low/high is $0.16/$2.67.
Rainbow Coral Corp. and its biotech subsidiary, Rainbow Biosciences, are hard at work positioning for explosive growth in next-gen pharmaceutical technologies space, which has become a major driver in the burgeoning $60B global drug delivery market. The company is diligently striving to change the drug-delivery paradigm and has announced that they are now in talks with a key emerging company that owns technology with the potential to enable selective, site-specific delivery, allowing for lower drug concentrations and greatly reducing the risk of drug toxicity.
Rainbow Coral Corp. (RBCC), via wholly owned subsidiary Rainbow Biosciences, continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. The company specifically pursues opportunities that offer short-term marketability and commercialization potential in key areas like Alzheimer's, Parkinson's, and Cancer.
Bioscience technology is a growing, dynamic field of innovation that applies life processes to practical uses, such as the manufacturing of medical devices and the development of new bioscience procedures. From pharmaceuticals to pacemakers, genetically engineered plants to gene therapy, bioscience technology can be found virtually anywhere.
The pending joint venture with Amarantus BioScience to develop and market new therapies and treatments for neurological diseases and physical traumas is a great example of the initiatives underway. In recent news, Amarantus licensed a highly promising diagnostic blood test that could become an invaluable new tool in Alzheimer's clinical trials where patient recruitment errors occur often due to inaccurate diagnosis.
The global biotech industry, currently valued at more than $84.6B, allows new players with bright ideas to quickly grab market share and create completely new markets. The exciting initiatives being driven forward by Rainbow Coral promise to transition today's leading-edge research into practical, affordable treatments for people who need them most. Disclaimer
Rainbow Coral Corp. Company Blog
Rainbow Coral Corp. News:
RBCC Tech Innovations Drive Big Growth in $60 Billion Drug Delivery Market
RBCC Nears Finalization of Partnership Agreement with Leading-Edge Pharmacogenomics Labs
Rainbow Coral Corp. (RBCC) Announces Engagement of QualityStocks Investor Relations Services
Cardium Therapeutics, Inc. (CXM)
The QualityStocks Daily Newsletter would like to spotlight Cardium Therapeutics, Inc. (CXM). Today, Cardium Therapeutics, Inc. closed trading at $0.168, up 1.82%, on 71,900 volume with 59 trades. The stock’s average daily volume over the past 60 days is 167,220, and its 52-week low/high is $0.15/$0.30.
Cardium Therapeutics, Inc. announced some expansion today via the company's To Go Brands® operating unit, as the VitaRocks® kids vitamins product line sees retail distribution of the newly-designed products broadened into select Target stores. This is a great way to get kids to take their vitamins and is patterned after the famous popping pellet candy, promising an easy-use delivery platform for multivitamins, nutrients, dietary supplements, and potentially over-the-counter medicines for children as well as adults.
Cardium Therapeutics, Inc. (CXM) is a health sciences and regenerative medicine company focused on acquiring and strategically developing new and innovative products and businesses to address significant unmet medical needs. Comprised of large-market opportunities with definable pathways to commercialization, partnering, and other economic monetizations, Cardium's current portfolio includes the Tissue Repair Company, Cardium Biologics, and the company's in-house MedPodium Health Sciences healthy lifestyle product platform.
The company's lead commercial product Excellagen® topical gel for wound care management recently received FDA clearance for marketing and sale in the United States. In addition to plans to advance the product's commercialization in the U.S. and internationally via strategic partnerships, the company plans to develop new product extensions for additional wound healing applications and is working towards securing approval for marketing and sale in South Korea and through the CE Mark application process in the European Union.
Generx®, Cardium's lead clinical development product candidate, is a DNA-based angiogenic biologic designed to treat patients with myocardial ischemia due to coronary artery disease. Cardium recently initiated its Generx Phase 3 / registration study in Russia. Consistent with its capital-efficient business model, Cardium is also actively evaluating new technologies and business opportunities. The company utilizes its team's skills in late-stage product development to bridge the critical gap between promising new technologies and product opportunities that are ready for commercialization.
Cardium is dedicated to building on its core products and product candidates to continually create new opportunities for greater success. Leveraging the advantages of its capital-efficient, asset-based business strategy, the company provides a diversified and more balanced portfolio of risk/return opportunities with the chief objective of providing long-term shareholder value. Disclaimer
Cardium Therapeutics, Inc. Company Blog
Cardium Therapeutics, Inc. News:
Cardium's To Go Brands® to Launch Expanded VitaRocks® kids Vitamin Line With New Retail Distribution
Cardium's Excellagen® Awarded American Podiatric Medical Association Seal of Approval, Company Also Announces Addition of a Regional Distributor for Excellagen
Cardium Announces Presentation at The 2013 Cell & Gene Therapy Forum
Advaxis, Inc. (ADXS)
The QualityStocks Daily Newsletter would like to spotlight Advaxis, Inc. (ADXS). Today, Advaxis, Inc. closed trading at $0.09, up 0.11%, on 1,730,561 volume with 105 trades. The stock’s average daily volume over the past 60 days is 4,758,004, and its 52-week low/high is $0.0275/$0.155.
Advaxis, Inc. reported today that the company has been nominated for the “Best Early-Stage Vaccine Biotech” Vaccine Industry Excellence Award for the second year in a row. Nomination in this influential awards ceremony, sponsored by industry giant Novartis, boldly signifies to the entire sector that ADXS' tremendous progress advancing their lead program in the clinic, as well as the achievement of proof-of-concept for ADXS-HPV in cervical cancer, is valid. Winners will be announced April 17, 2013, at the 6th annual ViE Awards Ceremony & Gala Dinner held in conjunction with the 13th Annual World Vaccines and Expo Conference to be held April 16-18 in Washington, DC.
Advaxis, Inc. (ADXS) is a clinical-stage biotechnology company developing the next-generation of immunotherapies for cancer and infectious diseases. The company’s immunotherapies are based on a novel platform technology that uses live, bio-engineered bacteria to secrete an antigen/adjuvant fusion protein that redirects the powerful immune response all human beings have to fight off cancer and disease.
The company has more than fifteen distinct constructs in various stages of development, all of which are involved in strategic collaborations with recognized centers of excellence such as the National Cancer Institute, Cancer Research – UK, the Wistar Institute, the University of Pennsylvania, the University of British Columbia, the Karolinska Institutet, and others.
Advaxis’ lead construct, ADXS-HPV, is currently in Phase 2 clinical development for recurrent/refractory and advanced cervical cancer, CIN 2/3, and HPV caused head and neck cancers. This important construct was recognized as the Best Therapeutic Vaccine (approved or in development) at the 5th Annual Vaccine Industry Excellence (ViE) Awards by the vaccine industry and the journal Expert Reviews of Vaccines.
The estimated global market for immunotherapies is projected to exceed $37.2B by 2012, with cancer vaccines forecast to grow into an $8B market. Protected by 77 issued and pending patents, Advaxis is extremely well positioned to capitalize on the burgeoning opportunities in the healthcare sector as it advances the development of next-generation treatments for today’s most challenging diseases. Disclaimer
Advaxis, Inc. Company Blog
Advaxis, Inc. News:
Advaxis Nominated for Best Early-Stage Vaccine Biotech at 6th Annual Vaccine Industry Excellence Awards
Advaxis’ ADXS-cHER2 Immunotherapy Researchers Receive Penn One Health Award for Initiatives in Canine Osteosarcoma
Advaxis Provides Business Outlook for 2013
GlobalWise Investments, Inc. (GWIV)
The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $0.35, up 9.38%, on 37,665 volume with 7 trade. The stock’s average daily volume over the past 60 days is 14,814, and its 52-week low/high is $0.18/$1.87.
GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.
GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.
The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.
GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer
GlobalWise Investments Company Blog
GlobalWise Investments News:
GlobalWise Investments, Inc. Completes $3.0 Million Private Placement
GlobalWise Comments on Recent Balance Sheet Improvements, Channel Partners and Market Opportunities
GlobalWise CEO to Speak at Technology United Executive Conference
The next generation of advanced pharmaceutical technologies holds great potential and could fuel extraordinary growth in the $60 billion global drug delivery market. Rainbow Coral’s biotech subsidiary, Rainbow BioSciences, aims to be right in the middle of the action.
Some pharmaceutical giants believe new drug delivery methods will serve as a crucial growth generator, and new innovations are constantly taking place across the healthcare sector. Many experts believe that personalized medicine is the future of healthcare, and customized drug delivery has the potential to drastically change the way value is assessed and compensated in the U.S. healthcare system.
Rainbow Coral is diligently positioning itself to capitalize on the evolving drug-delivery paradigm by partnering with key players in the field. The company is now in talks with an emerging company that owns technology with the potential to enable selective, site-specific delivery, allowing for lower drug concentrations and greatly reducing the risk of drug toxicity. In addition to helping millions of patients struggling with chronic conditions, this bold new technology can also extend the patent life cycles of drugs, giving potential pharmaceutical partners a tremendous market advantage.
For more information, visit www.RainbowBioSciences.com
Earlier today, Cardium Therapeutics announced that its To Go Brands® division has expanded its VitaRocks® kids vitamins product line and that retail distribution of the newly-designed products is being been expanded to include select Target stores.
The VitaRocks products are inspired by a popping pellet candy that is popular with kids and represents a next-generation, easy-use delivery platform for multivitamins and nutrients, dietary supplements, and potentially over-the-counter (OTC) medicines for children as well as adults. The Kids VitaRocks product line tastes great and delivers important vitamins and minerals needed by the body. Each packet provides 50% of Daily Value, so that children four and above can safely enjoy this nutritious treat twice a day. VitaRocks products include cherryBLAST, grapeGUSHER, the new blueRAZZ, as well as orangeBURST, providing 250 mg of Vitamin C. To Go Brands’ adult VitaRocks C delivers a powerful dose of 1000 mg of Vitamin C in every packet.
“Special formulations allow VitaRocks to melt cleanly in the mouth and deliver vitamins and nutrients while being fun and great tasting. Unlike many other products in this class, VitaRocks require no mixing with water and can be directly consumed. While the initial product line was designed for children, with the success of new adult multivitamin chews and gummies, consumers of all ages are increasingly seeking easy-to-use and great tasting nutritional products, and we believe that our VitaRocks platform aligns with this important and rapidly emerging trend. Because of our unique manufacturing process, we now have the flexibility to expand the product line into formulas that could include enzymes, electrolytes, amino acids, vitamins and minerals, as well as nutrients, and into other applications including OTC drugs,” stated Hanna Wagari, Cardium’s Vice President of Sales and Marketing.
Current VitaRocks products are available through retailers, including Whole Foods, Sprouts and Vitamin Shoppe. The new product line will be available at the beginning of April 2013 in select Target stores, as well as directly from the To Go Brands web-based store at www.togobrands.com.
For more information on Cardium, visit www.cardiumthx.com
Biotech small-cap Advaxis has been nominated for the Vaccine Industry Excellence (ViE) Award sponsored by Novartis Vaccines and Diagnostics. The ViE award recognizes companies and individuals that have demonstrated influential accomplishments and contributions to the vaccine industry within the prior 12 months.
Nominees are selected according to criteria such as the company’s ability to advance their business from early stage to mature, create a quality and diverse pipeline, achieve clinical advancements, establish significant partnerships, and successfully secure funds for continued growth.
Advaxis chairman and CEO Thomas A. Moore detailed the company’s initiatives leading up to its second straight nomination for the ViE award.
“We are delighted to be nominated in two consecutive years for a ViE award,” Moore stated in the press release. “In 2012, we made tremendous progress advancing our lead program in the clinic and achieved proof-of-concept of ADXS-HPV in the indication of cervical cancer. Our mission is to continue to set the foundation to become the industry leader in immunotherapy drug development and HPV-associated cancer research. The nomination for Best Early-Stage Vaccine Biotech validates the company’s research and clinical development over the past year.”
The winner will be announced April 17, 2013, at the 6th annual ViE Awards Ceremony & Gala Dinner held in conjunction with the 13th Annual World Vaccines and Expo Conference to be held April 16-18 in Washington, DC.
For more information, please visit www.advaxis.com
Whenever the United States has been hit with a crisis, whether a war or industrial crisis, or even an economic crisis, it ultimately depends upon technology to turn things around. New ideas result in new technologies, which help win wars, jumpstart industries, and increase productivity and money flow. Such is the case with the oil industry crisis, when readily available American oil was being used up and the country was forced to turn increasingly to foreign suppliers. Peak U.S. oil production in the late 1960s and early 1970s led to a gradual and seemingly unstoppable decline lasting decades, with prices surging upward.
But then something happened. Money drives technology and oil’s high prices fueled major developments in both oil sourcing and oil production, opening up immense new opportunities for American oil. Techniques and equipment that didn’t exist before are now allowing companies to find and remove oil that was previously unavailable, turning the world oil picture on its head. Suddenly, U.S. oil production is growing again, and is expected to continue growing for years. It is even expected that the U.S. could eventually become the world’s largest oil producer, and perhaps a net exporter in the not too distant future.
And yet, without drilling support companies like HII Technologies, not a drop of American oil would flow. That’s because power and water and other services all need to be in place before drilling can even begin, and that’s exactly what HII Technologies has developed its reputation doing. With primary operations in Texas and Oklahoma, the company has shown that their oilfield technologies and services provide a key advantage to their many customers, solutions that include manufacturing, machining, field services, and proprietary industrial product lines.
HII Technologies is already benefitting from America’s oil revolution, and now has expansion plans in other active areas such as North Dakota and Utica shale play areas.
For additional information, visit www.HIITInc.com
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) Nominated for Best Early-Stage Vaccine Biotech at 6th Annual Vaccine Industry Excellence Awards
- Bergamo Acquisition Corp. (BGMO) Provides Authenticated Documentation to Confirm Bank Deposits
- Consorteum Holdings, Inc. (CSRH) Reaches Funding Agreement With Private Equity Group
- Cardium Therapeutics, Inc. (CXM) To Go Brands® to Launch Expanded VitaRocks® kids Vitamin Line With New Retail Distribution
- Duma Energy Corp. (DUMA) Receives 1.1 Billion Barrel P10 Estimate for Namibia Concession
- GlobalWise Investments, Inc. (GWIV) CEO to Speak at Technology United Executive Conference
- HII Technologies, Inc. (HIIT) Announces Engagement of QualityStocks Investor Relations Services
- International Stem Cell Corp. (ISCO) Strengthens Intellectual Property Portfolio
- Loans4Less.com, Inc. (LFLS) Engages CPA Firm to Audit Financials
- Rafarma Pharmaceuticals, Inc. (RAFA) Receives General License for Pharmaceutical Products Starts Mfg. 3 New Products
- Rainbow Coral Corp. (RBCC) Tech Innovations Drive Big Growth in $60 Billion Drug Delivery Market
- The Guitammer Company Inc. (GTMM) and State of Ohio Modify Terms of "Innovation Loan"
- Viaspace, Inc. (VSPC) 25 Acres of Giant King Grass Shipped and Growing in St. Croix
- Viscount Systems, Inc. (VSYS) Receives Canadian Government Support to Enhance Its Freedom Access Control Platform and Expand System Capabilities
- VistaGen Therapeutics, Inc. (VSTA) to Present Enhancements and Expanded Validation of LiverSafe 3D™ at Society of Toxicology's 52nd Annual Meeting